Because the small bowel is a site of significant cholesterol synthesis, we determined the ileal distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase), the rate-limiting enzyme of the cholesterol biosynthetic pathway. Immunofluorescence microscopy on unfixed snap-frozen sections of ileum and jejunum from untreated rats or dogs showed HMG-CoA reductase in the absorptive villus epithelial cells and this appeared to be strikingly localized in their apical cytoplasm. This pattern of HMG-CoA reductase staining approximated a gradient along the villus-crypt axis with the distal villi labeling most intensely. Treatment of rats with mevinolin and/or cholestyramine for 12 days induced a 5-to 11-fold increase in ileal HMG-CoA reductase activity, and yielded a higher intensity of immunostaining without altering the pattern of enzyme distribution observed in control intestines. Also, rats with maximal induction of ileal HMG-CoA reductase exhibited a twofold increase in the number of epithelial villus cells containing prominent stacks of smooth-surfaced membranes in their apical cytoplasm as seen with electron microscopy. These observations suggest that the distal villus absorptive epithelial cells of the ileum contain high concentrations of HMG-CoA reductase, and therefore might be capable of contributing significant quantities of cholesterol to the circulation.
M evinolin is a very effective serum cholesterol-lowering agent in both humans and dogs, where significant reductions have been observed when the drug is used alone or in combination with bile acid sequestrants. 1 " 5 This powerful hypolipidemic effect occurs because mevinolin is a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase; EC 1.1.1.34), a microsomal enzyme catalyzing the rate-limiting reaction of cholesterol synthesis. 6 However, chronic studies in rats show that compactin, a related but somewhat less active reductase inhibitor, does not reduce blood cholesterol in this species, 6 " 8 presumably because treatment with HMG-CoA reductase inhibitors causes a significant increase in enzyme levels in rat livers. 79 " 11 In recent immunofluorescence and electron microscopic studies of mevinolin-treated rats, we observed a dramatic induction of HMG-CoA reductase-containing hepatocytes which contained greatly expanded smooth endoplasmic reticulums, and which were localized periportally. 12 These data suggest that the periportal regions of the liver might be specialized for heightened cholesterol synthesis. Since the small intestine (particularly the ileum) also plays a key role in mammalian cholesterol synthesis, 13 ' 14 we have now lo-calized HMG-CoA reductase in the ileum of normal and mevinolin-treated rats and dogs. Contrary to previous biochemical determinations, 13 " 15 we find that HMG-CoA reductase is heavily concentrated in the absorptive epithelial cells of the distal villi and greatly reduced in the crypt cells.
Methods

Chemicals
Mevinolin, a fungal metabolite, was isolated from Aspergillus terreus (ATCC #20542) at Merck as described. 6 Purified rat liver HMG-CoA reductase and rabbit antisera to HMG-CoA reductase were provided by Genen C. Ness (University of South Florida, Tampa, Florida). Cholestyramine and fluorescein isothiocyanate-conjugated affinity purified goat antirabbit IgG were obtained from Merck or Boehringer-Mannheim Biochemicals, Indianapolis, Indiana.
Animals
Sprague-Dawley rats (Charles River Company, 200 g, male, 7 weeks old) were housed under reversed lighting (12 hours dark/12 hours light). They consumed Purina rat laboratory chow containing the test compounds (wt/wt percent) ad libitum; controls were fed standard chow. The rats were anesthetized with CO 2 and were sacrificed by cervical dislocation at the diurnal high point (10 AM) for HMG-CoA reductase. Beagle dogs (8 to 10 kg, male, 32 to 38 weeks old) were fed Purina dog chow and housed under normal lighting conditions. They were treated orally once a day with mevinolin capsules (180 mg/kg/day) for 9 weeks; the controls received encapsulated lactose. Sacrifice was performed by ketamine injection and exsanguination. All animals were handled according to the guidelines for the care and use of laboratory animals (Institute of Laboratory Animal Resources, National Research Council).
Microscopy
Segments of ileum or jejunum (5 cm in length) were rapidly dissected and irrigated with 0.1 M phosphate buffer (pH 7.2); liver samples were also taken from each animal. For immunofluorescence (IF) microscopy, tissues were mounted on cork slices and quenched in liquid nitrogencooled Freon 22. Cryostat sections (5 /urn) were stained for HMG-CoA reductase using monospecific rabbit IgG as previously described. 12 To avoid nonspecific labeling of intestinal tissue, we used a modified "blotto" method. 16 Before staining, the sections were incubated for 20 minutes with blotto supernatant [5% (wt/vol) nonfat dry milk in 0.1 M phosphate buffer (pH 7.8) containing 0.1 % NaN 3 and 0.1% bovine serum albumin (BSA) centrifuged at 15,000 g for 10 minutes]. After washing in 0.1 M Tris buffer (pH 7.8), the sections were stained with purified (protein A-Sepharose) monospecific rabbit anti-HMG-CoA reductase IgG (100 /ng/ml) followed by the fluorochrome conjugate (1:25 dilution) in 0.1 % dry milk, 0.1 % BSA, 0.1 % NaN 3 and 0.1 M phosphate buffer (pH 7.8) clarified at 15,000 g. Coverslips were mounted on the stained sections with glycerol containing 4% n-propyl gallate which greatly reduced fading of the fluorescent label during microscopy.
Immunofluorescent micrographs were taken with a Zeiss Photomicroscope III equipped with an epifluorescence condenser III RS, and X10, X16, or X63 Neofluar objective lenses using llford HP5 film, and were processed with Microphen fine grain developer at 1600 ASA. Exposures were made with the use of two different methods: either the automatic mode or the standard mode. With the automatic method, the microscope selected the proper exposure time in relation to the fluorescence intensity of the slide, which varied from one sample to another. Therefore, we used this method to document our initial description of the distribution of HMG-CoA reductase within the ileum of control and compound-treated animals. The standard exposure mode was used in semiquantitative experiments performed to compare the relative amounts of reductase staining among various specimens. With this method, the microscope photometer was used to determine the proper exposure time on the most intensely labeled sample, and all subsequent specimens were photographed with that exposure setting. For electron microscopy (EM), the ileal mucosa was rapidly dissected out, macerated finely in fixative (2% glutaraldehyde, 3.5% paraformaldehyde, 0.1 M sucrose, 0.1 M phosphate buffer, pH 7.2), and processed as previously described. 12
Results
Localization of Intestinal HMG-CoA Reductase
When sections of ileum obtained from rats fed a standard diet were labeled with monospecific HMG-CoA re-ductase IgG, IF microscopy showed that this enzyme was strikingly localized in the intestinal epithelium ( Figure 1A and 1C). HMG-CoA reductase was most concentrated in the apical portions of the epithelial cells above their nuclei ( Figure 1A ). The labeling intensity appeared reduced at the basal portions of the villi, and was markedly diminished in the crypts; the lamina propria and epithelial goblet cells were unlabeled ( Figure 1C ). No background staining was seen in control sections stained with nonimmune rabbit IgG followed by fluorescein-conjugated goat antirabbit IgG using the modified blotto protocol ( Figure 1B ). Very similar staining patterns were observed in the ilea of rats given mevinolin ( Figure 1D and 1E), 3% cholestyramine (not shown), or cholestyramine plus mevinolin ( Figure 1F to 1H). All drug-treated rats exhibited a staining gradient for HMG-CoA reductase with the high point in the distal villi, and the nadir localized in the crypts ( Figure 1D and 1F). Corresponding liver sections from these rats exhibited the expected increases in HMG-CoA reductase-containing periportal hepatocytes (not shown) that have been reported previously. 12 To further substantiate these results, the intestines of dogs were also stained for HMG-CoA reductase. Control dogs showed similar distal-to-basal gradients of HMG-CoA reductase distribution and zones of enzyme concentration in the apical absorptive cell cytoplasm ( 
Induction of HMG-CoA Reductase Staining
Several techniques were used to determine whether mevinolin and cholestyramine treatment induced increases in the content of ileal HMG-CoA reductase. Using an in vitro enzyme assay system, 5.6-to 11.8-fold elevations in reductase activity were observed in pooled ileal epithelial microsomes after compound administration (Table 1). Evidence that these increases in activity reflect an actual induction in the ileal content of HMG-CoA reductase was obtained from electrophoretic transfer-blot experiments ( Figure 2 ). Western blots of crude microsome pellets isolated from control ilea exhibited a reductase band at the 52 kD position (Lane 2), and showed a conspicuous induction of HMG-CoA reductase-stained bands after treatment with mevinolin and cholestyramine (Lane 1). A similar, but more striking, stimulation of reductase staining was observed in liver microsomes isolated from the same animals (Lanes 3 and 4). (These data lend further credence to the specificity of our HMG-CoA reductase antibodies since all the stained proteins seen in our Western blots migrated at the molecular masses of native reductase, or its proteolytic cleavage products.) As a final check of mevinolin-induced reductase staining in the ileum, semiquantitative immunofluorescence staining experiments were performed using a standardized exposure mode ( Figure 3) . A very obvious increase in reductase staining intensity was observed in the ileal villi of rats treated with cholestyramine and mevinolin relative to the control specimens ( Figure 3A and 3C ). Both levels of staining were completely eliminated by preincubating the reductase antibodies with excess purified HMG-CoA reductase ( Figure  3B and 3D).
Electron Microscopy oflleum from Drug-Treated Rats
Since HMG-CoA reductase is a microsomal membraneintercalated protein 17 localized predominantly in the smooth endoplasmic retjculum (SER), 18 our IF and enzyme assay data prompted us to determine whether in-creased membrane accumulation occurs in the lleum of mevinolin/cholestyramine-treated rats. Electron micrographs from specimens with the highest levels of induced intestinal HMG-CoA reductase activity (11.8-fold increase following 3% cholestyramine and 0.25% mevinolin) showed conspicuous accumulations of dense stacks of smooth membranes in the apical regions of ileal villus ab- *llea were cut open, washed thrice with phosphate buffer; the epithella were Isolated using a Stomacher extractor. Enzyme activities were determined on pooled epithelial cell microsomes (4 rats per group) as previously described. 6 ' 12 'Compounds were given for 12 days. t 3 % cholestyramine was given for 9 days, followed by 0.25% mevlnolin plus 3% cholestyramine for 3 days. sorptjve cells ( Figure 4A ) where HMG-CoA reductase was localized ( Figure 1E and 1G) . These membranous stacks were composed of flattened, smooth-surfaced saccules associated with rough endoplasmic reticulum ( Figure 4B and 4C). Similar membranous structures were found in control ileal villus cells ( Figure 4D ), but they were much less numerous and did not extend into the apical cytoplasm. Double-blind morphometric analysis of our micrographs showed that 75% of the ileal villus absorptive cells from mevinolin/cholestyramine-treated rats exhibited prominent stacks of smooth membranes, while only 35% of the villus cells from control animals contained these membranes ( Figure 5 ). No other morphological differences were observed between the intestines of compound-treated and control rats.
Discussion
Using IF microscopy on cryostat sections of freshly frozen unfixed rat ileum, we observed that HMG-CoA reductase was distributed in a gradient along the villus-crypt axis. The staining for HMG-CoA reductase was maximal in the distal villus, moderate in the basal villus, and least intense in the crypts. This HMG-CoA reductase labeling was limited to the villus epithelial absorptive cells, where it was concentrated in the apical cytoplasm just inside the brush border. Treatment with mevinolin and/or cholestyramine raised the ileal HMG-CoA reductase levels of activity from 5-to 11-fold, but did not alter the graded pattern of HMG-CoA reductase and had no apparent effect upon its intracellular localization in either rats or dogs. However, ilea from compound-treated rats showed a conspicuous induction of HMG-CoA reductase immunofluorescence staining in villus enterocytes compared with the controls. These observations are consistent with the idea that an induction of ileal HMG-CoA reductase synthesis took place in response to the administration of mevinolln and cholestyramine. This hypothesis is supported further by the appearance of increased quantities of reductase in electro-immunoblots of ileal (as well as liver) microsomes obtained from compound-treated rats, relative to the controls.
We believe that the staining in our Immunofluorescent micrographs is specific for ileal HMG-CoA reductase because this staining is eliminated by preincubating the reductase antibodies with excess purified HMG-CoA reductase before use in our labeling protocol. Also, no staining is seen if nonimmune rabbit IgG is substituted for reductase antibodies in our procedure. In addition, the fact that we observed an induction of HMG-CoA reductase immunostaining in both our ileal micrographs and our electroimmunoblots, which correlates with increased reductase activity after mevinolin/cholestyramine treatment, further strengthens this belief.
Morphometric analysis of our electron micrographs of the ileum showed that the number of absorptive enterocytes containing prominent stacks of smooth-surfaced membranes increased by more than twofold in mevinolin/ cholestyramine-treated rats exhibiting maximal induction of HMG-CoA reductase. These membranous stacks were often found to be closely associated with the endoplasmic reticulum. Because HMG-CoA reductase is an integral membrane protein shown to be mainly situated in the endoplasmic reticulum, 17 " 19 one would expect to see increases In the content of endoplasmic reticulum membranes to accommodate newty synthesized reductase in 1 116 92 66 45 i Figure 2 . Electrophoretic transfer-blot analysis of crude microsome pellets isolated as previously described^ 12 from control and mevtnolln/cholestyramlne-treated rat ileai and liver fractions. This blot shows specific labeling of HMG-CoA reductase and induction of increased reductase content in the compound-treated tissues. Staining was performed with 68 iiQlm\ rabbit anti-HMG-CoA reductase IgG, followed by peroxldose-conjugated goat antirabbit IgG using the "blotto" method. 18 Lane 1.30 ^g of ileal microsomes pooled from rats treated with 3% cholestyramine for 9 days followed by 3% cholestyramlne and 0.25% mevinolin for 3 days. response to mevinolin treatment. Although we have observed membrane accumulation associated with mevino lin/cholestyramine administration, not all of the absorptive epithelial cells had stacks of smooth-surfaced membranes, despite the uniform induction of reductase immunofluorescence staining in the distal villus epithelium. Similarly, the less intensely labeled, but uniformly stained, control Heal villus epithelium also exhibited smooth membranous stacks in 38% of the enterocytes, while the remainder of the cells sampled lacked such membranes. These results suggest that a loose association exists between the quantities of reductase and microsomal membrane synthesized on a per-cell basis.
The dense stacks of smooth-surfaced membranes observed in compound-treated enterocytes have the morphological characteristics of the Golgi apparatus, 20 ' 21 but we do not have any other cytochemical evidence showing that these membranes are Golgi-related. Such morphological observations suggest that increased cholesterol synthesis stimulates Golgi activity. This hypothesis is sup-ported by the appearance of a conspicuous Golgi apparatus in corpus luteal cells during maximal progesterone secretion, 22 and the formation of striking stacks of flattened membranous saccules in the juxtanuclear cytoplasm of hepatocytes synthesizing very high levels of HMG-CoA reductase. 12 However, HMG-CoA reductase has unprocessed high manose sugars suggesting that this enzyme does not pass through the Golgi apparatus. The homogeneous distribution of HMG-CoA reductase fluorescence labeling in the apical ileal cytoplasm without apparent concentration in the Golgi region favors this suggestion. Therefore, it is likely that the induced smoothsurfaced membranes that we observed are components of the smooth endoplasmic reticulum.
Several workers have attempted to measure regional differences in intestinal cholesterol synthesis and HMG-CoA reductase activity using biochemical or physical methods to separate villus epithelial cells from crypt cells, and their results have been contradictory. While two groups 2324 showed that the ileal villi exceed the crypts in (arrowhead) . B. Preparation similar to that in A stained with anti-HMG-CoA reductase IgG that was pre-incubated with excess purified rat liver HMG-CoA reductase. This treatment eliminated the immunolabeling of the ileal epithelium (arrowhead). C. Substantial HMG-CoA reductase staining is found In the rat ileum (arrowhead) following treatment with 3% choiestyramine (9 days) and 0.25% mevinolin plus 3% choiestyramine (3 days). D. Intense HMG-CoA reductase staining similar to that shown in C, in the mevinolin/cholestyramine-treated Ileum (arrowhead), is blocked by pretreating the HMG-CoA reductase antibody with purified HMG-CoA reductase. both cholesterol synthesis and HMG-CoA reductase activity, another laboratory 13 -14 found that the lower villi had a higher rate of cholesterol synthesis than the crypts and upper villi; still others 15 showed that HMG-CoA reductase activity was highest in the crypt cells, or that the rate of villus sterol synthesis was equal to that of the crypts. 25 These discrepancies are probably caused by technical problems such as poor separation of cell types, cell lysis, incomplete enzyme recovery, enzyme inactivation, or pool effects which alter the specific activities of radiolabeled cholesterol precursors. 13 We believe that the morphological techniques utilized in our work permit a very precise definition of the cell types that are rich in HMG-CoA reductase, and therefore probably active in cholesterol synthesis. Furthermore, since we studied freshly frozen unfixed tissue, enzyme inactivation and loss should be minimal. Our results are in complete agreement with the autoradiographic studies of Mak and Trier 28 who observed that the upper ileal villi had the greatest quantities of mevalonate Incorporation into cholesterol, while reduced labeling was found in the lower villi and crypts. Although it is possible that the apical villus concentrations of HMG-CoA reductase labeling could signify inactive enzyme (i.e., due to phosphorylation 27 ), we believe, based on the above autoradiographic observations, 26 and the careful cell fractionation work of Merchant and Heller, 23 that this staining pattern represents high concentrations of functional reductase. Taken together, these observations suggest that the absorptive cells of the distal villi in the ileum are probably capable of active cholesterol synthesis, and thus may contribute significantly to the plasma cholesterol pool.
